Prof Dr. Rosa María Martínez-Espinosa | Genetics Award | Best Researcher Award

Prof Dr. Rosa María Martínez-Espinosa, University of Alicante, Spain

Rosa María Martínez-Espinosa, in Alicante, Spain, is a distinguished researcher and academic in the field of Biochemistry and Molecular Biology. She earned her PhD from the University of Alicante, where she was awarded the Extraordinary Doctorate Award. Her postdoctoral research at the University of East Anglia (2004-2008) was funded by various prestigious organizations, including the European Commission. In 2011, she joined the University of Alicante as a Lecturer and later established the “Applied Biochemistry” research group in 2017. Promoted to Full Professor in 2020, her research focuses on extremophile microorganisms, enzyme characterization, genetic manipulation, carotenoid production, and bioremediation processes, contributing to over 100 scientific publications and numerous national and international presentations. An award-winning educator recognized for her teaching excellence, she has held various academic leadership roles, including Vice-President for International Relations and Development Cooperation. With a robust track record in project evaluation and accreditation, Rosa continues to influence the field through her research and commitment to academic excellence.

Professional Profile:

ORCID

Summary of Suitability for Best Researcher Award:

Rosa María Martínez-Espinosa is an exemplary candidate for the Best Researcher Award due to her significant contributions to the fields of biochemistry and molecular biology. With over 100 scientific publications in indexed journals, an H-index of 28, and extensive experience in both research and teaching, she has established herself as a leader in her field.

Education:

PhD in Biology
1999 – 2003
Department of Agrochemistry and Biochemistry, University of Alicante, Spain
- Received the Extraordinary Doctorate Award.
BSc (Hons) in Biology
1994 – 1998
Faculty of Science, University of Alicante, Spain.

Work Experience:

Vice President for International Relations and Development Cooperation
December 2020 – Present
University of Alicante, Spain.
Vice-Dean of Postgraduate Programs
December 2016 – December 2020
University of Alicante, Spain.
- Academic coordinator for mobility and training at companies.
Academic Coordinator
December 2013 – November 2016
Faculty of Sciences, University of Alicante, Spain.
- Supervised mobility and training at companies.
Coordinator of the Degree of Biology
June 2012 – November 2014
Faculty of Sciences, University of Alicante, Spain.
Assistant Professor
October 2004 – 2011
Department of Agrochemistry and Biochemistry, University of Alicante, Spain.
- Included three research visits (total of 9.5 months) to Professor David J. Richardson’s laboratory, University of East Anglia, UK.
Associate Professor
October 2001 – October 2004
Department of Agrochemistry and Biochemistry, University of Alicante, Spain.
- Included a 3-month research visit to Professor David J. Richardson’s laboratory, University of East Anglia, UK.
Senior Lecturer
August 2011 – August 2020
Department of Agrochemistry and Biochemistry, University of Alicante, Spain.
Full Professor
August 2020 – Present
Department of Agrochemistry and Biochemistry, University of Alicante, Spain.

Publication top Notes:

The Antitumour Mechanisms of Carotenoids: A Comprehensive Review

Bacterioruberin: Biosynthesis, Antioxidant Activity, and Therapeutic Applications in Cancer and Immune Pathologies

Molecular Advances in Microbial Metabolism 2.0

Controversy over the Use of “Shade Covers” to Avoid Water Evaporation in Water Reservoirs

Halophilic Carotenoids and Breast Cancer: From Salt Marshes to Biomedicine

Prof Dr. Sergey Deev | Genetics | Best Paper Award

Member of Russian Academy of Sciences, Member of Academia Europaea, Head of Molecular Immunology Laboratory, Russia

Dr. Sergey M. Deyev is a distinguished Professor and a full member of the Russian Academy of Sciences. Renowned for his contributions to molecular immunology, Dr. Deyev is currently the Deputy Chairman of the Expert Council for Biology at the Russian Foundation for Basic Research and leads the Molecular Immunology Laboratory at the Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry. His career spans several decades, characterized by groundbreaking research in targeted cancer therapies and nanoparticle applications.

Education 🎓:

Dr. Deyev completed his M.Sc. in Chemistry from Lomonosov Moscow State University in 1973, followed by a Ph.D. in Molecular Biology from the Engelhardt Institute of Molecular Biology in 1977. His Doctor of Science (D.Sc.) in Molecular Biology was awarded in 1990, with his thesis focusing on the structure and rearrangements of immunoglobulin genes.

Experience 💼:

Dr. Deyev has held prominent roles in academia and research institutions. Since 2000, he has served as the Head of the Molecular Immunology Laboratory at the Shemyakin & Ovchinnikov Institute. He also holds professorships at multiple prestigious institutions, including Lomonosov Moscow State University and the National Research Nuclear University “MEPhI.” His extensive experience includes positions as a visiting professor and researcher internationally, furthering his impact in molecular biology and immunology.

Research Interests 🔬:

Dr. Deyev’s research focuses on developing nanotechnology-based solutions for targeted cancer therapies, including using nanoparticles for diagnostic bioimaging and tumor treatment. His lab specializes in the targeted delivery of nano-agents, high-affinity protein complexes, and genetic engineering of recombinant proteins. He is recognized for discovering the barnase-barstar protein pair, which has applications in drug delivery and immunotherapy.

Awards 🏆:

Throughout his career, Dr. Deyev has received numerous honors, including the prestigious “For Merit to the Fatherland” medal in 2018, the Shemyakin Prize in 2016, and the Mechnikov Prize for contributions to immunology and biotechnology. His membership in Academia Europaea and the Russian Academy of Sciences underscores his significant influence in the scientific community.

Publications Top Notes📚:

Dr. Deyev has co-authored many high-impact research papers, including recent notable publications:

“Flash drug release from nanoparticles accumulated in the targeted blood vessels facilitates the tumour treatment” in Nature Communications (2022) (DOI: 10.1038/s41467-022-34718-3), which has been cited for its contributions to advancing cancer treatment methodologies.

“Switchable targeting of solid tumors by BsCAR T cells” in Proceedings of the National Academy of Sciences USA (2022) (DOI: 10.1073/pnas.2210562119), noted for innovative approaches in T cell-mediated cancer targeting.